Search research articles
Contact Us
Filters
Showing results (301-310 of 309) with videos related to
Page
of 31
Sort By:
You have reached the last page of results.
This site can display upto 309 results.
The Lancet. Infectious Diseases
|
March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin, Cesar A Arias, Lauren Komarow, et al.
Blood Advances
|
January 20, 2026
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Christopher Fan, Tomo Hayase, Chia-Chi Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions
Minggui Wang, Lizhao Ge, Liang Chen, et al.
The Lancet. Infectious Diseases
|
November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
Minggui Wang, Michelle Earley, Liang Chen, et al.
The Lancet. Microbe
|
February 12, 2023
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
Jinnethe Reyes, Lauren Komarow, Liang Chen, et al.
Elife
|
January 30, 2023
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
Issam I Raad, Ray Hachem, Nigo Masayuki, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 13, 2022
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship
Issam Raad, Ray Hachem, Nigo Masayuki, et al.
The Journal of Clinical Investigation
|
November 15, 2022
Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
Rebecca A Drummond, Jigar V Desai, Amy P Hsu, et al.
The New England Journal of Medicine
|
June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia
, Todd C Lee, Lauren A Barina, et al.
Page
of 31
Search research articles
Search
Showing results (301-310 of 309) with videos related to
Sort By:
Page
of 31
You have reached the last page of results.
This site can display upto 309 results.
The Lancet. Infectious Diseases
|
March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
David van Duin, Cesar A Arias, Lauren Komarow, et al.
Blood Advances
|
January 20, 2026
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Christopher Fan, Tomo Hayase, Chia-Chi Chang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions
Minggui Wang, Lizhao Ge, Liang Chen, et al.
The Lancet. Infectious Diseases
|
November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
Minggui Wang, Michelle Earley, Liang Chen, et al.
The Lancet. Microbe
|
February 12, 2023
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
Jinnethe Reyes, Lauren Komarow, Liang Chen, et al.
Elife
|
January 30, 2023
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
Issam I Raad, Ray Hachem, Nigo Masayuki, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 13, 2022
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship
Issam Raad, Ray Hachem, Nigo Masayuki, et al.
The Journal of Clinical Investigation
|
November 15, 2022
Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
Rebecca A Drummond, Jigar V Desai, Amy P Hsu, et al.
The New England Journal of Medicine
|
June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia
, Todd C Lee, Lauren A Barina, et al.
Page
of 31